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Hematopoietic stem cells (HSCs) must at times exit quiescence to divide and produce differentiated blood
cells. In this issue ofCell Stem Cell, Takubo et al. (2013) and Yu et al. (2013) show that these opposing actions
require distinct metabolic programs to meet the changing energy demands of self-renewing HSCs.Adult somatic stem cells are involved in
the maintenance and repair of many
organs and are particularly important in
tissues with high cellular turnover such
as the blood system. In this context, an
outstanding question is how self-renew-
ing stem cells preserve their functional
activity while, at the same time, mini-
mizing the risk of acquiring damages
that would disrupt tissue homeostasis.
Blood-forming hematopoietic stem cells
(HSCs) have adopted a strategy wherein
they are primarily maintained in a resting,
quiescent (G0) state in specialized bone
marrow (BM) niches, where they can
sense changes occurring in the microen-
vironment and respond by rapidly prolifer-
ating to produce the needed blood cells
(Pietras et al., 2011). Over the last few
years, it has become increasingly clear
that HSCs harbor unique biological prop-
erties that distinguish them from more
committed progenitors and mature blood
cells. In this issue of Cell Stem Cell, two
complementary papers by the laborato-
ries of Dr. Toshio Suda (Takubo et al.,
2013) and Dr. Cheng-Kui Qu (Yu et al.,
2013) dissect one unique aspect of HSC
biology—their metabolic wiring—taking
us a step closer to understanding HSC
stemness.
Emerging evidence has linked meta-
bolic activity of stem cells, including
HSCs, with their functional behavior
(Folmes et al., 2012). Previous studies
have shown that quiescent HSCs reside
in hypoxic niches in the BM cavity
and rely heavily on anaerobic glycolysis,
rather than mitochondrial oxidative phos-
phorylation, to support ATP production
(Simsek et al., 2010; Suda et al., 2011).
Here, Takubo et al. (2013) advance this
line of research by performing metabo-
lome analyses of highly purified mouse
HSCs using mass spectrometry, which isa remarkable feat considering the rarity
of this BM population. They show that
the metabolic wiring of HSCs is very
different from committed blood progeni-
tors and is characterized by a high flux
through the glycolytic pathway. In partic-
ular, HSCs accumulate high levels of
fructose 1,6-bisphosphate, which reflects
an irreversible commitment to glycolysis,
together with low levels of phosphoenol-
pyruvate and elevated pyruvate, which
are respectively the substrate and
product of the final ATP-generating step
of the glycolytic pathway. They also find
high pyruvate kinase activity in quiescent
HSCs, which confirms their reliance
upon glycolysis for energy production.
Previously, the same authors showed
that hypoxia-inducible factor 1 alpha
(Hif-1a) is essential to maintain HSC func-
tion, since its deletion in mice resulted
in a loss of quiescence associated with
decreased reconstitution ability in trans-
plantation assays (Takubo et al., 2010).
Here, they delve deeper into the function
of this transcription factor and demon-
strate that Hif-1a is essential for maintain-
ing anaerobic glycolysis in HSCs. They
show that Hif-1a drives expression of
pyruvate dehydrogenase kinase (PDK) 2
and 4, which actively prevent pyruvate
from entering the TCA cycle and engaging
mitochondrial oxidative phosphorylation.
Moreover, they find that overexpression
of either Pdk2 or Pdk4 rescues the glyco-
lytic and functional defects observed in
HSCs lacking Hif-1a and that deletion of
both Pdk2 and Pdk4 results in decreased
dependence on anaerobic glycolysis and
HSC functional exhaustion similar to Hif-
1a deletion. Hence, Takubo et al. (2013)
demonstrate that resting HSCs in their
hypoxic BM niches rely on a Hif-1a-driven
metabolic program to prevent engage-
ment of the TCA cycle and maintainCell Stem Celanaerobic glycolysis as a source of
energy. Their results highlight a key
feature of self-renewing HSCs, which is
their need to limit mitochondrial respira-
tion to be maintained in a quiescent, func-
tional state.
The use of anaerobic glycolysis has
clear protective advantages for resting
HSCs, given that the alternative meta-
bolic pathway, mitochondrial oxidative
phosphorylation, is associated with the
production of DNA-damaging reactive
oxygen species (ROS). However, consid-
ering that anaerobic glycolysis is a
relatively inefficient method of ATP
production, would it be sufficient to
provide the energy needed for HSCs
undergoing self-renewal or differentia-
tion-associated divisions? In a com-
panion paper, Yu et al. (2013) address
this question by blocking mitochondrial
respiration through conditional inactiva-
tion of Ptpmt1, a PTEN-like mitochondrial
phosphatase, in mice. They find that
disrupting mitochondrial oxidative phos-
phorylation completely blocks HSC
differentiation and results in rapid hema-
topoietic failure. Surprisingly, this is not
due to a loss of the HSC compartment,
since phenotypic HSCs were increased
by 40-fold, but to the complete inability
of Ptpmt1-deficient HSCs to undergo
differentiation-associated divisions either
in an in vivo or in vitro setting. Yu et al.
(2013) confirm that Ptpmt1-deficient
hematopoietic stem and progenitor cells
(HSPCs) have decreased mitochondrial
respiration and show that they compen-
sate by increasing their levels of anaer-
obic glycolysis. This probably allows
for increased self-renewal divisions and
contributes to the accumulation of func-
tionally aberrant HSCs that they observe
in Ptpmt1-deficient mice. Thus, Yu et al.
(2013) highlight another essential featurel 12, January 3, 2013 ª2013 Elsevier Inc. 1
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Figure 1. The Changing Metabolic Landscape of Self-Renewing HSCs
HSCs utilize the low ATP-producing anaerobic glycolysis in their resting, quiescent state but switch to mitochondrial oxidative phosphorylation to support the
increasing energy demands associated with differentiation. In quiescent HSCs, the hypoxia-induced Hif-1a transcription factor drives expression of Pdk2/4,
which actively suppresses intracellular metabolites from entering the TCA cycle. In activated HSCs, the phosphatase Ptpmt1 primes a switch to mitochondrial
oxidative phosphorylation, which increases ATP production and enables differentiation-associated divisions. Questionmarks indicate several outstanding issues
regarding the status and repression of Hif-1a-mediated metabolic programs in activated HSCs.
Cell Stem Cell
Previewsof self-renewing HSCs, which is that
they cannot properly differentiate when
they are unable to engage mitochondrial
oxidative phosphorylation to generate
energy.
Collectively, these two stories draw a
compelling model in which self-renewing
HSCs rely heavily on anaerobic glycolysis
to maintain their quiescent state but need
to rapidly switch to mitochondrial oxida-
tive phosphorylation to facilitate the
robust energy demands associated with
differentiation (Figure 1). They provide
evidence that HSC metabolic programs
can be reworked to suit the changing
energy and functional demands of the
cells. Could we now take advantage
of this emerging understanding of HSC
metabolic pathways to expand self-re-
newing HSCs ex vivo? HSCs currently
cannot be cultured for more than a few
days before losing most of their self-2 Cell Stem Cell 12, January 3, 2013 ª2013 Erenewal ability, which stresses the impor-
tance of the regulations provided by their
native BM niches. Strikingly, Takubo et al.
(2013) show that culturing HSCs in
the presence of 1-aminoethylphosphinic
acid (1-AA), which decreases the likeli-
hood of pyruvate entering the TCA cycle
and thus mimics the effect of hypoxia-
induced Hif-1a, allows for the mainte-
nance of engrafting HSCs for at least
4 weeks. This exciting result suggests
that forcing HSCs to utilize anaerobic
glycolysis could indeed be used to
expand HSCs in vitro. Although the yields
are currently low, this technique holds
promise for therapeutic utility if combined
with other strategies that will favor self-
renewal divisions, such as preventing
inhibitory feedback signaling (Csaszar
et al., 2012), and will also preserve intact
the differentiation-associated switch to
mitochondrial respiration.lsevier Inc.It will now be fascinating to delve
deeper into the regulation of these two
opposing metabolic programs in quies-
cent and activated HSCs. For instance,
does HSC movement out of hypoxic
BM niches and decreased Hif-1a/Pdk2/4
activity actually precede mitochondrial
respiration? Is Ptpmt1 directly modulating
Pdk2/4 activity and is there another
regulator(s) controlling the switch to
mitochondrial oxidative phosphorylation
in activated HSCs? Do quiescent HSCs
rely on metabolic pathways other than
anaerobic glycolysis for their functional
maintenance? A recent study suggests
that this might be the case by finding
that fatty acid oxidation is also essential
for HSC maintenance (Ito et al., 2012),
hence raising questions about its cross-
regulation by Hif-1a and hypoxia. More-
over, do quiescent HSCs solely rely upon
Hif-1a for sensing the demand of their
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Previewsenvironment or are other master regula-
tors of stress response pathways such
as FoxO3a or p53 (Warr et al., 2011) also
important in tailoring the metabolic
makeup of self-renewing HSCs? Lastly,
aremutations in Pdk2/4 orPtpmt1 associ-
ated with blood diseases and do leu-
kemia-initiating stem cells have changes
in their metabolic wiring that would make
themdistinct fromnormal HSCsandcould
be amenable to therapeutic intervention?
These are just a few of the myriad ques-
tions that are emerging from these two
exciting works, which have brought us
a step closer to understanding HSC stem-
ness from the standpoint of regulation of
energy supply and demand.REFERENCES
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Knowing when to stop proliferation is crucial for any regenerative process. In a recent issue of Nature, Barry
et al. (2012) report that the Hippo pathway component YAP negatively regulates Wnt signaling, thereby
preventing stem cell overpopulation after a regenerative response in the intestine.During homeostasis a complex interplay
of morphogenetic pathways preserve
epithelial integrity in the gut. These path-
ways, which include Wnt and Notch
signaling, maintain a functional stem cell
pool and regulate differentiation pro-
cesses. More recent data indicate that
the same signaling cascades are crucial
for proper tissue regeneration after injury
of the adult intestine. For example, it has
been demonstrated not only that Wnt
signaling is critical for gut repair but also
that artificial increase of Wnt activity,
e.g., by infusion of the Wnt agonist
R-spondin1, augments the efficacy of
the regenerative response (Kim et al.,
2005).
In contrast to our rather extensive
knowledge of pathways that regulatestem cell properties in the intestine during
homeostasis and tissue regeneration,
only a very limited number of studies
examine the mechanisms that keep
stem cells in check after a regenerative
response to prevent tissue overcrowding
and dysplasia. An important player in
this so-called ‘‘crowd control’’ mecha-
nism is the Hippo pathway. This pathway,
originally discovered in Drosophila, is
most well known for its ability to regulate
organ size (reviewed in Mauviel et al.,
2012). When the Hippo cascade is active,
the downstream effector of this pathway
Yes-associated protein (YAP) is phos-
phorylated at S127 by the LATS1/2
kinases. Phosphorylated YAP remains in
the cytoplasm and as such cannot exert
its proproliferative and antiapoptoticfunction in the nucleus, which is mainly
mediated by its binding to TEAD1-4 tran-
scription factors. In addition, cytoplasmic
YAP can directly antagonize the Wnt
pathway, thereby further contributing to
the role of Hippo signaling in preventing
proliferation and stem cell expansion
(Konsavage and Yochum, 2012).
The relevance of the Wnt antagonizing
effects of YAP in controlling intestinal
stem cell expansion after regeneration
was recently uncovered in an elegant
series of experiments performed in the
Camargo laboratory (Barry et al., 2012).
Barry et al. (2012) report that epithelial-
specific overexpression of the YAP
(S127A) mutant, which importantly is pre-
dominantly localized in the cytoplasm in
this tissue, induces intestinal hypotrophyl 12, January 3, 2013 ª2013 Elsevier Inc. 3
